Is There a Rationale for Using Bacillus Calmette-Guerin Vaccine in Coronavirus Infection?

Area of Science:

• Immunology
• Infectious Diseases
• Vaccinology

Background:

• Coronavirus disease 2019 (COVID-19) is a global pandemic with no approved treatments.
• Prevention strategies like masks and hygiene are crucial but not sustainable long-term.
• Development of a vaccine is essential to halt the spread of COVID-19.

Purpose of the Study:

• To explore the potential of the Bacillus Calmette-Guerin (BCG) vaccine as a prophylactic measure against coronavirus infection.
• To investigate the hypothesis that BCG's known immunostimulatory effects may offer protection against COVID-19.

Main Methods:

• Review of existing literature on BCG vaccine and its known effects.
• Analysis of speculations regarding BCG's immunostimulatory and antiviral properties.
• Identification of the need for clinical studies to validate the hypothesis.

Main Results:

• Currently, no published evidence supports the use of BCG vaccine for preventing coronavirus infection.
• BCG vaccine is a live attenuated vaccine used for tuberculosis prophylaxis and is widely available.
• BCG vaccine is known to have immunostimulatory and antiviral effects.

Conclusions:

• The hypothesis that BCG vaccine may enhance immunity and prevent coronavirus infection requires validation.
• Clinical studies in vulnerable populations are necessary to confirm the efficacy of BCG vaccine for COVID-19 prevention.
• Further research is imperative to establish BCG's role in combating the COVID-19 pandemic.